NeurAxon(USA), Inc. — Form D
NeurAxon(USA), Inc. of Mississauga, A6, a company, filed a Form D exempt-offering notice with the SEC on 2012-05-01. The offering totals $3.0M, of which $782K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-05-01
- Form: D
- Accession: 0001486097-12-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $782K
- Remaining: $2.2M
- Investors: 4
- Date of first sale: 2012-03-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-177521
Issuer
- Name: NeurAxon(USA), Inc.
- CIK: 0001486097
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2395 Speakman Drive, Mississauga, A6, L5K 1B3
- Phone: 416-673-6697
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| John S Andrews | Director | Mississauga, A6 |
| Aaron S Davidson | Director | Menlo Park, CA |
| Kenneth S Galbraith | Director | Mississauga, A6 |
| Deepa S Pakianathan | Director | Mississauga, A6 |
| John S Andrews | Executive Officer | Mississauga, A6 |
| Tom S Lategan | Executive Officer | Mississauga, A6 |
| Shawn S Maddaford | Executive Officer | Mississauga, A6 |
| Suman S Rakhit | Executive Officer | Mississauga, A6 |
| Samuel P Wertheimer | Director | New York, NY |
| Kenneth A Galbraith | Director | Princeton, NJ |
| Aaron A Davidson | Director | Newtown, PA |
| Tom A Lategan | Executive Officer | Toronto, A6 |
| Shawn A Maddaford | Executive Officer | Toronto, A6 |
| Lawrence E Bloch | Director | Toronto, A6 |
| Lawrence E Bloch | Executive Officer | Toronto, A6 |
| Deepa R Pakianathan | Director | Toronto, A6 |
| Robert A Medve | Executive Officer | Toronto, A6 |
| Suman A Rakhit | Executive Officer | Toronto, A6 |
| Andrew A Sandham | Director | Toronto, A6 |
| Jonathan R Goodman | Director | — |
Other filings by this issuer (1)
More